Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
ezpeptides.com
Samples
Passed
Failed
Trust score updated: June 2, 2026 · 100% pass rate
Composite score based on 95 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| May 29, 2026 | KPV | HPLC purity | PASS | 99.181% | Janoshik Analytical | Lot EZP-KPV1005152026-12 · Report 166066 |
| May 29, 2026 | Cagrilintide | HPLC purity | PASS | 99.87% | Janoshik Analytical | Lot EZP-CAG0505152026-12 · Report 166063 |
| May 29, 2026 | N-Acetyl Semax Amidate | HPLC purity | PASS | 99.19% | Janoshik Analytical |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 95 COAs attributed to this vendor. Last recomputed 2026-06-02.
Business CPaaS phone (-0.02), Full identity on file (0.03)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot EZP-SEMX1005182026-10 · Report 166072 |
| May 29, 2026 | PT-141 | HPLC purity | PASS | 99.912% | Janoshik Analytical | Lot EZP-PT1005172026-08 · Report 166069 |
| May 29, 2026 | N-Acetyl Selank Amidate | HPLC purity | PASS | 99.589% | Janoshik Analytical | Lot EZP-SEL1005192026-08 · Report 166075 |
| May 25, 2026 | GLOW Blend (GHK-Cu/TB-500/BPC-157) | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP - GLOW05122026-09 · Report 167761 |
| May 25, 2026 | BPC-157/TB4 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot BPCTB40505112026-09 · Report 163741 |
| May 25, 2026 | BPC-157 | HPLC purity | PASS | 99.934% | Janoshik Analytical | Lot EZP - BPC1005082026-22 · Report 163729 |
| May 25, 2026 | KLOW Blend (GHK-Cu/TB-500/BPC-157/KPV) | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP - KLOW8005112026-06 · Report 167758 |
| May 25, 2026 | Semaglutide | HPLC purity | PASS | 99.747% | Janoshik Analytical | Lot EZP-1P1005102026-03 · Report 163735 |
| May 25, 2026 | Retatrutide | HPLC purity | PASS | 99.767% | Janoshik Analytical | Lot EZP-3P0605132026-02 · Report 163747 |
| May 18, 2026 | Tirzepatide | HPLC purity | PASS | 99.77% | Janoshik Analytical | Lot EZP-2P3004212026-03 · Report 155920 |
| May 18, 2026 | 3P | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-3P2405072026-01 · Report 156377 |
| May 15, 2026 | CJC-1295 No DAC/Ipamorelin Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-CJCIPA504292026-09 · Report 155923 |
| May 15, 2026 | Sermorelin | HPLC purity | PASS | 99.071% | Janoshik Analytical | Lot EZP-SER0505052026-05 · Report 164164 |
| May 15, 2026 | Melanotan 2 | HPLC purity | PASS | 99.76% | Janoshik Analytical | Lot EZP-MEL21005032026-06 · Report 164160 |
| May 15, 2026 | Melanotan 1 | HPLC purity | PASS | 99.85% | Janoshik Analytical | Lot EZP-MEL11005072026-04 · Report 164162 |
| May 15, 2026 | Epitalon | HPLC purity | PASS | 99.446% | Janoshik Analytical | Lot EZP-EPIT1004202026-09 · Report 164156 |
| May 15, 2026 | GHK-Cu | HPLC purity | PASS | 99.699% | Janoshik Analytical | Lot EZP-GHK5005072026-14 · Report 167751 |
| May 15, 2026 | Retatrutide | HPLC purity | PASS | 99.564% | Janoshik Analytical | Lot EZP-3P2405072026-01 · Report 155945 |
| May 15, 2026 | NAD+ | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-NAD50005032026-17 · Report 155932 |
| Apr 28, 2026 | Tirzepatide | HPLC purity | PASS | 99.69% | Janoshik Analytical | Lot EZP-2P1004162026-03 · Report 149296 |
| Apr 27, 2026 | CJC-1295 No DAC / Ipamorelin Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-CJCIPA504122026-08 · Report 149290 |
| Apr 27, 2026 | BPC-157 | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-BPC50004162026-01 · Report 149297 |
| Apr 23, 2026 | 5-Amino-1MQ | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-AMINOMQ5004162026-03 · Report 149293 |
| Apr 20, 2026 | 2P | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-2P3004062026-02 · Report 151257 |
| Apr 17, 2026 | N-Acetyl Selank Amidate | HPLC purity | PASS | 99.6% | Janoshik Analytical | Lot EZP-SEL1004042026-07 · Report 137189 |
| Apr 17, 2026 | TB-500 | HPLC purity | PASS | 99.872% | Janoshik Analytical | Lot EZP-TBF1004082026-04 · Report 137198 |
| Apr 17, 2026 | KPV | HPLC purity | PASS | 99.707% | Janoshik Analytical | Lot EZP-KPV1004082026-11 · Report 137201 |
| Apr 17, 2026 | BPC/TB4 Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-BPCTB41004062026-03 · Report 137195 |
| Apr 14, 2026 | MOTS-C | HPLC purity | PASS | 99.73% | Janoshik Analytical | Lot EZP-MOT1003302026-18 · Report 136296 |
| Apr 14, 2026 | Ipamorelin | HPLC purity | PASS | 99.157% | Janoshik Analytical | Lot EZP-IPA1003282026-14 · Report 136293 |
| Apr 14, 2026 | Retatrutide | HPLC purity | PASS | 99.909% | Janoshik Analytical | Lot EZP-3P1004012026-02 · Report 147745 |
| Apr 7, 2026 | Tirzepatide | HPLC purity | PASS | 99.845% | Janoshik Analytical | Lot EZP-2P2003252026-03 · Report 132876 |
| Apr 7, 2026 | Tirzepatide | HPLC purity | PASS | 99.939% | Janoshik Analytical | Lot EZP-2P6003282026-02 · Report 136240 |
| Apr 2, 2026 | Retatrutide | HPLC purity | PASS | 99.809% | Janoshik Analytical | Lot EZP-3P1204012026-02 · Report 134639 |
| Apr 2, 2026 | BAC Water | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-BAC1004012026-08 · Report 136612 |
| Apr 2, 2026 | Beauty Blend GHK/KPV 50mg/20mg | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-GHKKPV7003172026-02 · Report 134617 |
| Apr 1, 2026 | Tesamorelin | HPLC purity | PASS | 99.84% | Janoshik Analytical | Lot EZP-TES1003212026-20 · Report 134378 |
| Mar 24, 2026 | Retatrutide/Cagrilintide Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-RETCAG1503142026-03 · Report 124539 |
| Mar 24, 2026 | Tesa/Ipa Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-TESIPA03152026-05 · Report 124541 |
| Mar 23, 2026 | N-Acetyl Semax/Selank Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot EZP-SEMXSEL1003052026-01 · Report 123919 |
| Mar 23, 2026 | DSIP | HPLC purity | PASS | 98.383% | Janoshik Analytical | Lot EZP-DSIP1003062026-02 · Report 123920 |
| Mar 23, 2026 | N-Acetyl Semax Amidate | HPLC purity | PASS | 99.957% | Janoshik Analytical | Lot EZP-SEMX1003072026-09 · Report 123921 |
| Mar 20, 2026 | Retatrutide | HPLC purity | PASS | 99.913% | Janoshik Analytical | Lot EZP-3P2003102026-01 · Report 123374 |
| Mar 10, 2026 | Cagrilintide | HPLC purity | PASS | 99.733% | Janoshik Analytical | Lot EZP-CAG0502262026-11 · Report 113787 |
| Mar 10, 2026 | Tirzepatide | HPLC purity | PASS | 99.717% | Janoshik Analytical | Lot EZP-2P1502272026-03 · Report 113825 |
| Mar 5, 2026 | Cagrilintide | HPLC purity | PASS | 99.18% | Janoshik Analytical | Lot EZP-CAG1002202026-01 · Report 112788 |
| Mar 5, 2026 | Retatrutide | HPLC purity | PASS | 99.812% | Janoshik Analytical | Lot EZP-3P4802242026-02 · Report 112808 |
| Mar 5, 2026 | GHK-Cu | HPLC purity | PASS | 99.78% | Janoshik Analytical | Lot EZP-GHK10002192026-05 · Report 112774 |